keyword
Keywords Annals of internal medicine, r...

Annals of internal medicine, review

https://read.qxmd.com/read/38739921/associations-of-testosterone-and-related-hormones-with-all-cause-and-cardiovascular-mortality-and-incident-cardiovascular-disease-in-men-individual-participant-data-meta-analyses
#1
REVIEW
Bu B Yeap, Ross J Marriott, Girish Dwivedi, Robert J Adams, Leen Antonio, Christie M Ballantyne, Douglas C Bauer, Shalender Bhasin, Mary L Biggs, Peggy M Cawthon, David J Couper, Adrian S Dobs, Leon Flicker, David J Handelsman, Graeme J Hankey, Anke Hannemann, Robin Haring, Benjumin Hsu, Sean A Martin, Alvin M Matsumoto, Dan Mellström, Claes Ohlsson, Terence W O'Neill, Eric S Orwoll, Matteo Quartagno, Molly M Shores, Antje Steveling, Åsa Tivesten, Thomas G Travison, Dirk Vanderschueren, Gary A Wittert, Frederick C W Wu, Kevin Murray
BACKGROUND: Whether circulating sex hormones modulate mortality and cardiovascular disease (CVD) risk in aging men is controversial. PURPOSE: To clarify associations of sex hormones with these outcomes. DATA SOURCES: Systematic literature review to July 2019, with bridge searches to March 2024. STUDY SELECTION: Prospective cohort studies of community-dwelling men with sex steroids measured using mass spectrometry and at least 5 years of follow-up...
May 14, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38739920/obesity
#2
REVIEW
Adam H Gilden, Victoria A Catenacci, John Michael Taormina
Obesity is a common condition and a major cause of morbidity and mortality. Fortunately, weight loss treatment can reduce obesity-related complications. This review summarizes the evidence-based strategies physicians can employ to identify, prevent, and treat obesity, including best practices to diagnose and counsel patients, to assess and address the burden of weight-related disease including weight stigma, to address secondary causes of weight gain, and to help patients set individualized and realistic weight loss goals and an effective treatment plan...
May 14, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38735694/end-of-life-care-for-cancer-patients-with-pre-existing-severe-mental-disorders-a-systematic-review
#3
JOURNAL ARTICLE
Haukur Svansson, Kirstine Bøndergaard, Poul Videbech, Mette Kjærgaard Nielsen, Jane Ege Møller, Louise Elkjær Fløe, Terese Myhre Bentson, Mette Asbjoern Neergaard
BACKGROUND: Cancer patients with pre-existing severe mental disorders (SMDs) less frequently receive guideline recommended cancer treatment and have a higher cancer mortality. However, knowledge is needed concerning end-of-life care in this patient group. The aim of this systematic review was to provide an overview of the literature concerning end-of-life care in cancer patients with pre-existing SMD. METHODS: A systematic search was conducted in the following databases: PubMed, Embase and Science Direct and all results were downloaded to Endnote on 1st of September 2023...
April 22, 2024: Annals of Palliative Medicine
https://read.qxmd.com/read/38710089/in-type-2-diabetes-the-effectiveness-and-side-effects-of-glp-1-ras-vary
#4
JOURNAL ARTICLE
Clare O'Brien, Sean F Dinneen
Yao H, Zhang A, Li D, et al. Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis. BMJ. 2024;384:e076410. 38286487.
May 7, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38710086/the-safety-of-outpatient-health-care-review-of-electronic-health-records
#5
JOURNAL ARTICLE
David M Levine, Ania Syrowatka, Hojjat Salmasian, David M Shahian, Stuart Lipsitz, Jonathan P Zebrowski, Laura C Myers, Merranda S Logan, Christopher G Roy, Christine Iannaccone, Michelle L Frits, Lynn A Volk, Sevan Dulgarian, Mary G Amato, Heba H Edrees, Luke Sato, Patricia Folcarelli, Jonathan S Einbinder, Mark E Reynolds, Elizabeth Mort, David W Bates
BACKGROUND: Despite considerable emphasis on delivering safe care, substantial patient harm occurs. Although most care occurs in the outpatient setting, knowledge of outpatient adverse events (AEs) remains limited. OBJECTIVE: To measure AEs in the outpatient setting. DESIGN: Retrospective review of the electronic health record (EHR). SETTING: 11 outpatient sites in Massachusetts in 2018. PATIENTS: 3103 patients who received outpatient care...
May 7, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38706629/aquaporin-4-aqp-4-immunoglobulin-g-seropositive-neuromyelitis-optica-a-review-and-case-report
#6
JOURNAL ARTICLE
C Nwaze, Y Eghwrudjakpor, N Chinedu-Anunaso
BACKGROUND: Neuromyelitis optica spectrum disorder (NMOSD) is a relatively new terminology composed to encompass patients with neuromyelitis optica (NMO) and related immunological conditions. The diagnosis of this condition requires a seropositive aquaporin-4 immunoglobulin G (AQP-4 IgG), the presence of at least one core clinical characteristic and the exclusion of alternative diagnoses. Very few cases have been reported in sub-Saharan Africa. OBJECTIVE: The aim of this article is to report a classical case of NMOSD with AQP-4 IgG seropositivity and normal brain, cervical and thoracic MRI findings...
December 2023: Annals of Ibadan Postgraduate Medicine
https://read.qxmd.com/read/38694388/can-modulation-of-gut-microbiota-affect-anthropometric-indices-in-patients-with-non-alcoholic-fatty-liver-disease-an-umbrella-meta-analysis-of-randomized-controlled-trials
#7
REVIEW
Ehsan Amini-Salehi, Sandeep Samethadka Nayak, Gautam Maddineni, Abinash Mahapatro, Mohammad-Hossein Keivanlou, Saman Soltani Moghadam, Azin Vakilpour, Maryam Sadat Aleali, Farahnaz Joukar, Mohammad Hashemi, Naeim Norouzi, Arash Bakhshi, Ali Bahrampourian, Fariborz Mansour-Ghanaei, Soheil Hassanipour
BACKGROUND AND AIM: Modulating the gut microbiota population by administration of probiotics, prebiotics, and synbiotics has shown to have a variety of health benefits in different populations, particularly those with metabolic disorders. Although the promising effects of these compounds have been observed in the management of patients with non-alcoholic fatty liver disease (NAFLD), the exact effects and the mechanisms of action are yet to be understood. In the present study, we aimed to evaluate how gut microbiota modulation affects anthropometric indices of NAFLD patients to achieve a comprehensive summary of current evidence-based knowledge...
May 2024: Annals of Medicine and Surgery
https://read.qxmd.com/read/38694299/connor-davidson-resilience-scale-a-systematic-review-psychometrics-properties-using-the-cosmin
#8
REVIEW
Hamid Sharif-Nia, David Sánchez-Teruel, Erika Sivarajan Froelicher, Sima Hejazi, Lida Hosseini, Fatemeh Khoshnavay Fomani, Mozhgan Moshtagh, Fereshteh Mollaei, Amir Hossein Goudarzian, Amir Babaei
BACKGROUND: Psychometrical evaluation of persons of diverse contexts and different populations, including general or clinical. OBJECTIVE: This review study aimed to evaluate the psychometrics quality of resilience scales. METHODS: International and Iranian databases were searched with MESH terms, including "psychometric", "validity", "reliability", "Connor-Davidson resilience scale", "Resilience scale", for published articles up to 1 February 2023...
May 2024: Annals of Medicine and Surgery
https://read.qxmd.com/read/38685802/promoting-speaking-up-behaviours-among-nurses-working-in-the-care-for-older-people-a-scoping-review
#9
REVIEW
Katrina Austen, Marie Hutchinson, John Hurley
AIM: To explore interventions employed to foster speaking-up behaviours of registered nurses (RNs) working in the care of older people. DESIGN: Scoping review. METHODS: The updated Joann Briggs Institute scoping review methodological guidelines were followed. DATA SOURCES: CINAHL, PubMed, PsycINFO, and Scopus were searched. RESULTS: A total of 1691 titles and abstracts were screened, resulting in 11 articles that met the inclusion criteria...
April 29, 2024: Journal of Clinical Nursing
https://read.qxmd.com/read/38684102/the-benefits-and-risks-of-receiving-investigational-solid-tumor-drugs-in-randomized-trials-a-systematic-review-and-meta-analysis
#10
REVIEW
Renata Iskander, Hannah Moyer, Dean Fergusson, Sean McGrath, Andrea Benedetti, Jonathan Kimmelman
BACKGROUND: Many patients participate in cancer trials to access new therapies. The extent to which new treatments produce clinical benefit for trial participants is unclear. PURPOSE: To estimate the progression-free survival (PFS) and overall survival (OS) advantage of assignment to experimental groups in randomized trials for 6 solid tumors. DATA SOURCES: ClinicalTrials.gov was searched for trials of investigational drugs with results posted between 2017 and 2021...
April 30, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38639549/newer-pharmacologic-treatments-in-adults-with-type-2-diabetes-a-systematic-review-and-network-meta-analysis-for-the-american-college-of-physicians
#11
REVIEW
Tyler Drake, Adrienne Landsteiner, Lisa Langsetmo, Roderick MacDonald, Maylen Anthony, Caleb Kalinowski, Kristen Ullman, Charles J Billington, Anjum Kaka, Shahnaz Sultan, Timothy J Wilt
BACKGROUND: Newer diabetes medications may have beneficial effects on mortality, cardiovascular outcomes, and renal outcomes. PURPOSE: To evaluate the effectiveness, comparative effectiveness, and harms of sodium-glucose cotransporter-2 (SGLT2) inhibitors, glucagon-like peptide-1 (GLP1) agonists, dipeptidyl peptidase-4 (DPP4) inhibitors, and long-acting insulins as monotherapy or combination therapy in adults with type 2 diabetes mellitus (T2DM). DATA SOURCES: MEDLINE and EMBASE for randomized controlled trials (RCTs) published from 2010 through January 2023...
April 19, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38639547/cost-effectiveness-of-newer-pharmacologic-treatments-in-adults-with-type-2-diabetes-a-systematic-review-of-cost-effectiveness-studies-for-the-american-college-of-physicians
#12
REVIEW
John T Schousboe, Adrienne Landsteiner, Tyler Drake, Shahnaz Sultan, Lisa Langsetmo, Anjum Kaka, Maylen Anthony, Charles J Billington, Caleb Kalinowski, Kristen Ullman, Timothy J Wilt
BACKGROUND: In the United States, costs of antidiabetes medications exceed $327 billion. PURPOSE: To systematically review cost-effectiveness analyses (CEAs) of newer antidiabetes medications for type 2 diabetes. DATA SOURCES: Bibliographic databases from 1 January 2010 through 13 July 2023, limited to English. STUDY SELECTION: Nonindustry-funded CEAs, done from a U.S. perspective that estimated cost per quality-adjusted life-year (QALY) gained for newer antidiabetic medications...
April 19, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38639546/newer-pharmacologic-treatments-in-adults-with-type-2-diabetes-a-clinical-guideline-from-the-american-college-of-physicians
#13
JOURNAL ARTICLE
Amir Qaseem, Adam J Obley, Tatyana Shamliyan, Lauri A Hicks, Curtis S Harrod, Carolyn J Crandall
DESCRIPTION: The American College of Physicians (ACP) developed this clinical guideline to update recommendations on newer pharmacologic treatments of type 2 diabetes. This clinical guideline is based on the best available evidence for effectiveness, comparative benefits and harms, consideration of patients' values and preferences, and costs. METHODS: This clinical guideline is based on a systematic review of the effectiveness and harms of newer pharmacologic treatments of type 2 diabetes, including glucagon-like peptide-1 (GLP-1) agonists, a GLP-1 agonist and glucose-dependent insulinotropic polypeptide agonist, sodium-glucose cotransporter-2 (SGLT-2) inhibitors, dipeptidyl peptidase-4 (DPP-4) inhibitors, and long-acting insulins, used either as monotherapy or in combination with other medications...
April 19, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38621248/rheumatology-what-you-may-have-missed-in-2023
#14
JOURNAL ARTICLE
Kafaf Jalali, Lisa A Mandl
Many patients with rheumatologic conditions receive care from physicians other than rheumatologists. Here we note key findings from 6 studies in rheumatology published in 2023 that offer valuable insights for internal medicine specialists and subspecialists outside of rheumatology. The first study investigated the effect of low-dose glucocorticoids on patients with rheumatoid arthritis (RA) over 2 years and challenged existing perceptions about the risks of glucocorticoids in this setting. The second study focused on the updated guideline for preventing and treating glucocorticoid-induced osteoporosis...
April 16, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38621245/pulmonology-what-you-may-have-missed-in-2023
#15
JOURNAL ARTICLE
Aram Karkar, Sana Khan, Rebecca O'Leary, Albina Tyker, Michael Unger
The field of pulmonology saw significant advances in 2023. The publications highlighted in this article address advances and changes in practice related to asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease, pleural disorders, and sleep-disordered breathing. One article reviews data examining the efficacy of vaccination against respiratory syncytial virus, a respiratory viral illness that has had devastating effects globally. Four studies evaluate the role of various therapies in COPD, including dupilumab, ensifentrine, pulmonary rehabilitation programs, and lung volume reduction versus endobronchial valves...
April 16, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38621241/gastroenterology-hepatology-what-you-may-have-missed-in-2023
#16
JOURNAL ARTICLE
Sama Anvari, Kayla Dadgar, Ciarán Galts, Michael Bretthauer
This article summarizes clinically important gastroenterology developments from 2023 for internal medicine specialists. In colorectal cancer screening, a new RNA fecal screening test is on the horizon, as well as a new analysis on the benefits of using artificial intelligence in screening colonoscopy to detect more polyps. There is new evidence for management of gastrointestinal bleeding, a new drug for treatment of recurrent small-intestinal angiodysplasia, and a new endoscopic treatment method in patients with gastrointestinal tumor bleeding...
April 16, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38599340/circulating-plasma-cells-as-a-predictive-biomarker-in-multiple-myeloma-an-updated-systematic-review-and-meta-analysis
#17
JOURNAL ARTICLE
Qun Li, Lisha Ai, Liping Zuo, Junying Li, Fei Zhao, Aoshuang Xu, Bo Zhang, Li Cai, Yu Hu, Chunyan Sun
BACKGROUND: Circulating plasma cells (CPCs) are defined by the presence of peripheral blood clonal plasma cells, which would contribute to the progression and dissemination of multiple myeloma (MM). An increasing number of studies have demonstrated the predictive potential of CPCs in the past few years. Therefore, there is a growing need for an updated meta-analysis to identify the specific relationship between CPCs and the prognosis of MM based on the current research status. METHODS: The PubMed, Embase, and Cochrane Library databases were screened to determine eligible studies from inception to November 5, 2023...
December 2024: Annals of Medicine
https://read.qxmd.com/read/38588546/long-term-effect-of-salt-substitution-for-cardiovascular-outcomes-a-systematic-review-and-meta-analysis
#18
REVIEW
Hannah Greenwood, Katelyn Barnes, Justin Clark, Lauren Ball, Loai Albarqouni
BACKGROUND: Salt substitution is a simple yet increasingly promising strategy to improve cardiovascular outcomes. PURPOSE: To evaluate the long-term effects of salt substitution on cardiovascular outcomes. DATA SOURCES: PubMed, EMBASE, Cochrane CENTRAL, and CINAHL searched from inception to 23 August 2023. Trial registries, citation analysis, and hand-search were also done. STUDY SELECTION: Randomized controlled trials (RCTs) comparing provision of or advice to use a salt substitute with no intervention or use of regular salt among adults for 6 months or longer in total study duration...
April 9, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38588539/annals-video-summary-long-term-effect-of-salt-substitution-for-cardiovascular-outcomes-a-systematic-review-and-meta-analysis
#19
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 9, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38576995/the-availability-access-challenges-and-advancements-in-neurosurgical-care-in-africa-a-mini-review
#20
REVIEW
Hassan Ahmed, Muhammad Furqan, Inibehe Ime Okon, Malik Olatunde Oduoye, Ugwu Onyedika Mitchell, Usoro Akpan, Florence Umutoni, Soham Bandyopadhyay, Aymar Akilimali, Menelas Nkeshimana
The availability and accessibility of neurosurgical care across Africa remains limited despite recent advancements. Overall, Africa accounts for 15% of the global neurosurgical disease burden but has access to less than 1% of neurosurgeons globally. While the number of neurosurgeons has increased in recent decades, huge workforce shortages remain, with the region facing the second-largest neurosurgical deficit. Access to adequate facilities and equipment is also lacking. Barriers like poverty, conflicts, and distance from care centres negatively impact patients' ability to access services...
April 2024: Annals of Medicine and Surgery
keyword
keyword
60264
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.